Evolent Health (EVH) Net Cash Flow (2015 - 2026)

Evolent Health has reported Net Cash Flow for 12 years, with the latest figure at -$27.0 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 72.94% year-over-year to -$27.0 million in Q2 2026; TTM through Jun 2026 was -$35.2 million, a 187.5% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, up 106.0% from the prior year.
• Net Cash Flow was -$27.0 million for Q2 2026 at Evolent Health, down from -$11.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $99.3 million in Q1 2025, with the low at -$99.8 million in Q2 2025.
• Average Net Cash Flow over 5 years is -$11.7 million, with a median of -$5.5 million recorded in 2023.
• The largest YoY upside for Net Cash Flow was 5063.93% in 2024 against a maximum downside of 711.04% in 2024.
• Over 5 years, Net Cash Flow stood at $20.4 million in 2022, then slumped by 105.02% to -$1.0 million in 2023, then jumped by 5063.93% to $50.8 million in 2024, then retreated by 25.33% to $37.9 million in 2025, then tumbled by 171.22% to -$27.0 million in 2026.
• The last three Net Cash Flow figures came in at -$27.0 million (Q2 2026), -$11.4 million (Q1 2026), and $37.9 million (Q4 2025), per Business Quant data.